188 related articles for article (PubMed ID: 37150266)
1. Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy.
Tseng PT; Zeng BS; Suen MW; Wu YC; Correll CU; Zeng BY; Kuo JS; Chen YW; Chen TY; Tu YK; Lin PY; Carvalho AF; Stubbs B; Li DJ; Liang CS; Hsu CW; Sun CK; Cheng YS; Yeh PY; Wu MK; Shiue YL; Su KP
Brain Behav Immun; 2023 Jul; 111():352-364. PubMed ID: 37150266
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids for the treatment of dementia.
Burckhardt M; Herke M; Wustmann T; Watzke S; Langer G; Fink A
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009002. PubMed ID: 27063583
[TBL] [Abstract][Full Text] [Related]
3. The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials.
Tseng PT; Zeng BY; Chen YW; Yang CP; Su KP; Chen TY; Wu YC; Tu YK; Lin PY; Carvalho AF; Stubbs B; Matsuoka YJ; Li DJ; Liang CS; Hsu CW; Sun CK; Cheng YS; Yeh PY; Shiue YL
Curr Neuropharmacol; 2022; 20(10):1816-1833. PubMed ID: 35450525
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
[TBL] [Abstract][Full Text] [Related]
5. High Dosage Omega-3 Fatty Acids Outperform Existing Pharmacological Options for Migraine Prophylaxis: A Network Meta-Analysis.
Tseng PT; Zeng BY; Chen JJ; Kuo CH; Zeng BS; Kuo JS; Cheng YS; Sun CK; Wu YC; Tu YK; Stubbs B; Carvalho AF; Liang CS; Chen TY; Hsu CW; Suen MW; Yang CP; Hsu SP; Chen YW; Shiue YL; Hung CM; Su KP; Lin PY
Adv Nutr; 2024 Feb; 15(2):100163. PubMed ID: 38110000
[TBL] [Abstract][Full Text] [Related]
6. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease.
Wood AHR; Chappell HF; Zulyniak MA
Eur J Nutr; 2022 Mar; 61(2):589-604. PubMed ID: 34392394
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: A network meta-analysis of randomized controlled trials.
Yang B; Tseng PT; Hu X; Zeng BY; Chang JP; Liu Y; Chu WJ; Zhang SS; Zhou ZL; Chu CS; Chang CH; Tu YK; Wu YC; Stubbs B; Carvalho AF; Lin PY; Matsuoka YJ; Suen MW; Su KP
Prog Lipid Res; 2022 Nov; 88():101196. PubMed ID: 36341839
[TBL] [Abstract][Full Text] [Related]
8. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
[TBL] [Abstract][Full Text] [Related]
9. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
Phillips MA; Childs CE; Calder PC; Rogers PJ
Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
[TBL] [Abstract][Full Text] [Related]
10. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
Liu TH; Wu JY; Huang PY; Lai CC; Chang JP; Lin CH; Su KP
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656283
[No Abstract] [Full Text] [Related]
12. Omega-3 polyunsaturated fatty acids in sarcopenia management: A network meta-analysis of randomized controlled trials.
Tseng PT; Zeng BY; Zeng BS; Liao YC; Stubbs B; Kuo JS; Sun CK; Cheng YS; Chen YW; Chen TY; Tu YK; Lin PY; Hsu CW; Li DJ; Liang CS; Suen MW; Wu YC; Shiue YL; Su KP
Ageing Res Rev; 2023 Sep; 90():102014. PubMed ID: 37442370
[TBL] [Abstract][Full Text] [Related]
13. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Chang JP; Tseng PT; Zeng BS; Chang CH; Su H; Chou PH; Su KP
Adv Nutr; 2023 Nov; 14(6):1326-1336. PubMed ID: 37567449
[TBL] [Abstract][Full Text] [Related]
14. Souvenaid for Alzheimer's disease.
Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer's Dementia in the Oldest Old.
Melo van Lent D; Egert S; Wolfsgruber S; Kleineidam L; Weinhold L; Wagner-Thelen H; Maier W; Jessen F; Ramirez A; Schmid M; Scherer M; Riedel-Heller SG; Wagner M
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33573174
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
Downie LE; Ng SM; Lindsley KB; Akpek EK
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055
[TBL] [Abstract][Full Text] [Related]
17. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.
Wei BZ; Li L; Dong CW; Tan CC; ; Xu W
Am J Clin Nutr; 2023 Jun; 117(6):1096-1109. PubMed ID: 37028557
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
19. The beneficial effect on cognition of noninvasive brain stimulation intervention in patients with dementia: a network meta-analysis of randomized controlled trials.
Tseng PT; Chen YW; Zeng BY; Zeng BS; Hung CM; Sun CK; Cheng YS; Stubbs B; Carvalho AF; Brunoni AR; Su KP; Tu YK; Wu YC; Chen TY; Lin PY; Liang CS; Hsu CW; Chu CS; Suen MW; Li CT
Alzheimers Res Ther; 2023 Jan; 15(1):20. PubMed ID: 36698219
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease.
Devassy JG; Leng S; Gabbs M; Monirujjaman M; Aukema HM
Adv Nutr; 2016 Sep; 7(5):905-16. PubMed ID: 27633106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
